Gilead Sciences, Inc. GILD shares are trading lower by $0.07 at $72.40 in Wednesday's session. Earlier in the session, the issue was lower as the entire sector was under pressure following a statement by Donald Trump that he intends to lower drug prices.
Off a lower open, it found support just ahead of its November 4 low ($71.39), only reaching $71.55, and rebounded. That November 4 low was lowest level for the issue since April 21, 2014, when it bottomed at $69.40.
The ensuing rally has found resistance just ahead of Monday's high ($72.97), only reaching $72.90, and has been consolidating at $72.40 area.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
